Casandra
Casandra Test Code QD56077Version 1 (DRAFT)
Performing Lab
Drug Monitoring, Oxycodone, Urine, with Confirmation
Clinical Use
Order TestUse
This test is intended to detect and confirm the presence of oxycodone in urine samples, typically for monitoring therapeutic compliance or misuse. It is used in clinical settings where verification of oxycodone usage is necessary through initial screening followed by confirmatory testing.
Special Instructions
If the initial screen for oxycodone in urine is positive, confirmation testing is performed at an additional charge.
Limitations
The test may not detect oxycodone in samples below cutoff, and confirmation is only performed following a positive screen; negative screening may not trigger confirmation.
Test Details
Methodology
Immunoassay
Biomarkers
Oxycodone
AnalytePresence/Absence • Other • Binary (Detected / Not Detected)
Result Turnaround Time
3-4 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
20 mL
Minimum Volume
7 mL
Container
Urine Collection Container
Related Tests
Other tests from different labs that may be relevant
Oxycodone/Oxymorphone, Screen and Confirmation, Urine
Labcorp
Oxycodone/Oxymorphone Confirmation (Labcorp MedWatch®)
Labcorp
Oxycodone with Metabolite Confirmation, Random, Urine
Mayo Clinic Lab
Oxycodone/Oxymorphone, Urine Screen with Reflex to Quantitation
ARUP Laboratories
Oxycodone Screen, Random, Urine
Mayo Clinic Lab
Oxycodone Screen, Chain of Custody, Random, Urine
Mayo Clinic Lab
Oxycodone/Oxymorphone, Screen Only, Urine
Labcorp
Oxycodone with Metabolite Confirmation, Chain of Custody, Random, Urine
Mayo Clinic Lab
Oxymorphone Confirmation, Random, Urine
Mayo Clinic Lab
Opiates Confirmation, Random, Urine
Mayo Clinic Lab